A plea for the wider use of CRT-P in candidates for cardiac resynchronisation therapy

Heart Failure Reviews

Volumn 17, Issue 6, 2012, Pages 767-775

  Daubert, Jean Claude ^a   Donal, Erwan ^b   Linde, Cecilia ^b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biventricular stimulation; Cardiac resynchronisation therapy; Heart failure; Implantable cardioverter defibrillator; Sudden death prevention

Indexed keywords

METOPROLOL;

ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL ASSESSMENT TOOL; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERMETHOD COMPARISON; INTERVENTION STUDY; MENTAL INSTABILITY; MORTALITY; NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS III; NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS IV; PERFORMANCE MEASUREMENT SYSTEM; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SHOCK; SUDDEN DEATH; SURVIVAL TIME; TREATMENT FAILURE;

CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS; PATIENT SELECTION; VENTRICULAR FIBRILLATION;

EID: 84868214586     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-011-9277-8     Document Type: Review

References (46)

1. Uretsky BF, Sheahan RG (1997) Primary prevention of sudden cardiac death in heart failure: will the solution be shocking? J Am Coll Cardiol 30:1589-1597
2. MERIT-HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL, randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001-2007
3. Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225-237
4. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388-2442
5. Jessup M, Abraham WT, Casey DE et al (2009) 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119:1977-2016
6. Cazeau S, Leclercq C, Lavergne T et al (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873-880
7. Abraham WT, Fisher WG, Smith AL, MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845-1853
8. Auricchio A, Stellbrink C, Sack S, Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group et al (2002) Long-Term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39:2026-2033
9. Higgins SL, Hummel JD, Niazi IK et al (2003) Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 42:1454-1459
10. Young JB, Abraham WT, Smith AL, Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators et al (2003) Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD trial. JAMA 289:2685-2694
11. Abraham WT, Young JB, Leon AR, Multicenter InSync ICD II Study Group et al (2004) Effects of cardiac resynchronization on disease progression in patients with left ventricular dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic heart failure. Circulation 110:2864-2868
12. Bristow MR, Saxon LA, Boehmer J, Comparison of Medical Therapy, Pacing, Defibrillation in Heart Failure (COMPANION) Investigators et al (2004) Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140-2150
13. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators (2005) The effect of cardiac resynchronization therapy on morbidity and mortality in heart failure. N Eng J Med 352:1539-1549
14. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, Kass DA, Powe NR (2003) Cardiac resynchronization and death from progressive heart failure: A meta-Analysis of randomized controlled trials. JAMA 289:730-740
15. McAlister EA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, Crumley E, Hartling L, Klassen T, Abraham W (2004) Systematic review: Cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 141:381-390
16. Rivero-Ayersa R, TheunsD,Garcia-GarciaH, Boersma E, Simoons M, Jordaens LJ (2006) Effects of cardiac resynchronization therapy on overall mortality and mode of death: A meta-Analysis of randomized controlled trials. Eur Heart J 27:2682-2688
17. Linde C, Leclercq C, Rex S et al (2002) Long-Term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 40:111-118
18. St. John Sutton MG, Plappert T, Abraham WT, Multicenter In-Sync Randomized Clinical Evaluation (MIRACLE) Study Group et al (2003) Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107:1985-1990
19. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L (2006) Longer-Term effects of cardiac resynchronisation therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 27:1928-1932
20. Bristow MR, Saxon LA, DeMarco T, Boehmer J, Galle E, Ecklund F, Feldman A (2005) What does an ICD add to CRT in advanced heart failure? An analysis of major clinical endpoints in the CRT vs CRT-D groups in the COMPANION trial. Circulation 112: II-673. Abstract
21. Lindenfeld JA, Feldman AM, Saxon L et al (2007) Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation 115:204-212
22. Vardas PE, Auricchio A, Blanc JJ, European Society of Cardiology; European Heart Rhythm Association et al (2007) Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European society of cardiology. Developed in collaboration with the European Heart Rhythm Association Eur Heart J 28:2256-2295
23. Epstein AE, DiMarco JP, Ellenbogen KA, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices), American Association for Thoracic Surgery, Society of Thoracic Surgeons et al (2008) ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117:e350-e408
24. Feldman AM, de Lissovoy G, Bristow MR et al (2005) Cost effectiveness of cardiac resynchronization therapy in the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) trial. J Am Coll Cardiol 46:2311-2321
25. Yao GL, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG (2007) The long-Term cost-effectiveness of cardiac resynchronisation therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 28:42-51
26. Kleeman T, Becker T, Doenges K, VaterM, Senges J, Schneider S, Saggau W, Weisse U, Seidl K (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of[10 years. Circulation 115:2474-2480
27. Maisel HM (2008) Semper fidelis-consumer protection for patients with implanted medical devices. N Engl J Med 358: 985-987
28. Saxon LA, Bristow MR, Boehmer J et al (2006) Predictors of sudden cardiac death and appropriate shock in the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) Trial. Circulation 114:2766-2772
29. Poole JE, Johnson GW, Hellkamp AS et al (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009-1017
30. Moss AJ, Hall WJ, MADIT-CRT Trial Investigators et al (2009) Cardiac-resynchronization therapy for the prevention of heartfailure events. N Engl J Med 361:1329-1338
31. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C, REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group (2008) Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 52:1834-1843
32. Packer M (2001) Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 7:176-182
33. Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Torok T, Linde C, Study Group REVERSE (2009) Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization reverses remodeling in systolic left ventricular dysfunction) trial. J Am Coll Cardiol 54: 1847-1849
34. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Bimie DH, Sapp JL, Yee R, Healey JS, Rouleau J (2010) Cardiac resynchronization therapy for mild-To-moderate heart failure. N Engl J Med 363:2385-2395
35. Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35:569-582
36. Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D et al (1993) Effects of the angiotensin converting enzyme inhibitor enalapril on the long-Term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (studies of left ventricular dysfunction) investigators. Circulation 88:2277-2283
37. Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusterman N (1996) Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA investigators. Circulation 94:2807-2816
38. The SOLVD Investigattors (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685-691
39. Ghio S, Freemantle N, Scelsi L, Serio A, Magrini G, Pasotti M, Shankar A, Cleland JG, Tavazzi L (2009) Long term left ventricular reverse remodelling with cardiac resynchronization therapy: Results from the CARE-HF trial. Eur J Heart Fail 11:480-488
40. Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E (2006) Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 113:266-267
41. St John Sutton M, Ghio S, Plappert T, Tavazzi L, Scelsi L, Daubert C, Abraham WT, Gold MR, Hassager C, Herre JM, Linde C, Esynchronization R, REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group (2009) Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure. Circulation 120:1858-1865
42. Solomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, Hall WJ, Pfeffer M, Moss AJ (2010) Effect of cardiac resynchronization therapy on reverse remodelling and relation to outcome. Circulation 122:985-992
43. Di Biase L, Gasparini M, Lunati M, Santini M, Landolina M, Boriani G, Curnis A, Bocchiardo M, Vincenti A, Denaro A, Valsecchi S, Natale A, Padeletti L, InSync/InSync ICD Italian Registry Investigators (2008) Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: The InSync ICD (implantable cardioverter-defibrillator) Italian registry. J Am Coll Cardiol 52:1442-1449
44. Dickstein K, Vardas P, Auricchio A, Daubert C, Linde C, Mc Murray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ (2010) Focused Update of ESC Guidelines on device therapy in heart failure Eur Heart J 31:2677-2687
45. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J, Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology (2003) The EuroHeart Failure Survey programme-A survey on the quality of care among patients with heart failure in Europe. Part 2: Treatment. Eur Heart J 24:464-474
46. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, van Veldhuisen DJ, Brugada J, Scientific Committee, National Coordinators (2009) The European cardiac resynchronization therapy survey. Eur Heart J 30:2450-2460